Visine

Medicinal product

(Invented) name

Visine

Active substance (s)

Tetrizolino hidrochloridas

Strength

0,5 mg/ml

Pharmaceutical form

akių lašai (tirpalas)

Route (s) of administration

vartoti ant akių

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01GA02, Tetryzoline

Marketing authorisation holder

McNeil Healthcare (Ireland) Limited, Airija

Date of authorisation

2021-03-05

Date of renewal

2025-10-17

Documents

4695_Visine_perr2025-10-17.docx

4695_pakuotes lapelis_2025-10-17.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

DE/H/5718/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Tetrizolino hidrochloridas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106080	92181	1092181	buteliukas	15 ml N1 (su lašintuvu)		Nereceptinis	LT/1/21/4695/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-10-17	Perregistruotas
2021-03-05	Registruotas